Gary Zhou 
Key Takeaways
- Wedbush analyst Dan Ives predicts Tesla and SpaceX merger in 2027, calling it a logical next step due to shared AI ambitions and operational ties.
- Tesla gained <1% stake in SpaceX after SpaceX acquired xAI, converting Tesla’s $2B investment; regulatory filings cleared in March 2026.
- Joint TERAFAB facility announced in Austin, Texas: two chip factories for Tesla’s vehicle/Optimus AI and SpaceX’s space data centers, seen as first integration step.
- SpaceX IPO expected mid-June 2026, raising ~$75B at $1.75T valuation to fund Starship, NASA lunar base, Starlink expansion, and orbital AI infrastructure.
- SpaceX plans solar-powered orbital satellites for AI data centers to bypass Earth’s energy constraints for exploding AI compute demand.
- Merger would form conglomerate in EVs, robotics, satellites, spaceflight, defense; benefits Tesla with SpaceX launch/orbital assets for autonomy and robots.
- Challenges include antitrust scrutiny, shareholder approvals; Musk seeks 25% Tesla ownership to steer AI amid regulatory hurdles.
- Ives maintains Outperform on Tesla with $600 price target, viewing merger as “holy grail” for Musk’s tech empire.
As a seasoned tech and EV industry blogger with over a decade tracking Elon Musk’s empire—from Tesla’s early Roadster days to SpaceX’s Starship triumphs—I’ve seen bold predictions come and go. But Wedbush analyst Dan Ives’ latest call on a potential Tesla-SpaceX merger by 2027 feels different. It’s not just hype; it’s backed by concrete moves like the joint TERAFAB chip factories and SpaceX’s impending mega-IPO. This could birth the ultimate AI-space conglomerate, blending EVs, robotics, satellites, and orbital computing. In this deep dive, we’ll unpack Ives’ thesis, the catalysts, risks, and what savvy investors should do next. ❶ ❷
The Spark: Dan Ives’ Bullish Tesla Outlook and Merger Vision
Dan Ives, Wedbush Securities’ Global Head of Tech Research, isn’t your average Wall Street voice—he’s a perennial Tesla bull with a track record of spotting Musk’s masterstrokes early. In his latest note, Ives reiterates an Outperform rating on Tesla (TSLA) with a $600 price target, implying nearly 55% upside from current levels. But the real bombshell? He views the freshly announced TERAFAB project as “the first step to ultimately what will be Tesla and SpaceX combining forces in a merger likely in 2027.” ❸ ❹
Ives calls this the “holy grail” for Musk’s tech empire, driven by:
- Shared AI ambitions: Tesla’s Dojo supercomputer, Optimus robots, and Full Self-Driving (FSD) tech crave massive compute. SpaceX’s Starlink and orbital plans offer the infrastructure.
- Operational synergies: Tesla already snagged a less-than-1% stake in SpaceX after SpaceX acquired xAI (converting Tesla’s $2B investment), with regulatory filings cleared in March 2026. ❺
My Take: Ives has been right before—his early bets on Tesla’s AI pivot paid off big. This merger talk aligns with Musk’s “Master Plan Part 5.0” whispers, where everything from Earth to Mars runs on integrated Musk tech.
TERAFAB: The Integration Catalyst No One Saw Coming
Announced just days ago (March 21-22, 2026), the joint TERAFAB facility in Austin, Texas is a $20-25 billion behemoth: two massive chip factories pumping out 100-200 billion custom AI and memory chips annually. Here’s the breakdown:
Core Purposes of TERAFAB
- For Tesla: Edge-inference processors for FSD autonomy in vehicles, Optimus humanoid robots, and energy products. This slashes reliance on Nvidia/TSMC amid AI chip shortages. ❻
- For SpaceX: Chips powering solar-powered orbital satellites as AI data centers—bypassing Earth’s energy grid limits for exploding global compute demand. ❼
- xAI Tie-In: Post-acquisition, it fuels Grok models for Musk’s AI ecosystem.
| Component | Tesla Focus | SpaceX Focus | Projected Output |
|---|---|---|---|
| Chip Fab 1 | FSD/Optimus AI inference | Orbital data center processors | 100B chips/year |
| Chip Fab 2 | Dojo supercomputer memory | Starlink AI edge computing | 100B chips/year |
| Total Cost | $10-12.5B (Tesla share) | $10-12.5B (SpaceX share) | $20-25B |
Insight: This isn’t just a factory—it’s Musk’s “galactic” play. By co-locating in Austin (near Tesla Gigafactory Texas), it signals deep integration. Critics call it “desperate” amid FSD delays, but I see it as prescient: AI compute wars demand vertical integration, à la Apple’s chip strategy. ❽
SpaceX IPO: Fueling the Merger Fireworks
Before any merger, SpaceX goes public—mid-June 2026, raising ~$75B at a staggering $1.75T valuation (some reports say $1.5T). Proceeds fund:
- Starship development and Mars missions.
- NASA lunar base contracts.
- Starlink expansion to 100K+ satellites.
- Orbital AI data centers via solar-powered sats. ❾ ❿
Timeline Snapshot:
- S-1 Filing: Expected early April 2026.
- Roadshow: May 2026.
- Pricing: Mid-June, potentially largest IPO ever. ⓫
Opinion: A public SpaceX makes merger math easier—Tesla shareholders get SpaceX equity without full dilution. Post-IPO, SpaceX’s $1.75T war chest positions it as the rocket for Musk’s AI dreams.
The Mega-Conglomerate Vision: Wins, Risks, and Hurdles
A merged entity would dominate:
- EVs & Robotics: Tesla’s core + Optimus fleets.
- Satellites & Spaceflight: Starlink + Starship.
- Defense & AI: Government contracts + orbital compute.
- Benefits for Tesla: Access to SpaceX launches for robot deployment and orbital autonomy testing.
Top Challenges:
- Antitrust Scrutiny: DOJ/FTC could balk at Musk’s monopoly in AI/space.
- Shareholder Votes: Musk wants 25% Tesla voting control for AI steering.
- Execution Risks: TERAFAB timelines (2-3 years to full output), FSD regulatory hurdles. ⓬
My Analysis: Probability? I’d peg it at 60-70% by 2027. Musk’s history (PayPal eBay vibes) shows he consolidates winners. Bears like Barclays’ Dan Levy dismiss TERAFAB as vaporware, but Ives’ $600 PT screams conviction.
Investment Advice: How to Position for the “Holy Grail”
- Buy TSLA Dips: Ives’ target justifies entry below $400. Long-term hold for merger pop.
- SpaceX Exposure: Secondary markets now; IPO allocation for institutions.
- Diversify Bets: ARK ETFs, chip plays (if TERAFAB succeeds).
- Watch Catalysts: SpaceX S-1 (April), TERAFAB groundbreaking (Q3 2026).
- Risk Management: 5-10% portfolio allocation—volatility ahead.
Pro Tip: Track Musk’s X posts and Ives’ notes religiously. This is peak Musk asymmetry: downside limited by cash flows, upside interstellar.
Musk’s Galactic Empire Takes Shape
Dan Ives isn’t predicting a merger—he’s mapping its blueprint via TERAFAB and SpaceX IPO. If it happens, we get a $3T+ behemoth rivaling Apple/Microsoft in AI dominance. Skeptics? Fair, but Musk defies odds. Stay tuned—this 2027 could eclipse 2020’s EV boom.
What do you think—merger mania or Musk mirage? Drop thoughts below!
